CIK 0001768224 · Accelerated filer<br>Smaller reporting company
Arcturus Therapeutics Holdings Inc.
Sign in to watch- Ticker
- ARCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 8589002660
- Business address
- 10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Regulation FD disclosure
- 4 Open-market buy See Remarks bought 450 shares at $33.33 ($14,999)
- 4 Open-market buy President and CEO bought 1,000 shares at $31.69 ($31,690)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $29.74 ($148,700)
- 8-K Event Shareholder vote results
- SC 13D/A Stake Beneficial Ownership Report
- S-3/A Offering Registration Statement
- 4 Option exercise Director acquired 600,000 shares (option exercise)
- EFFECT Other Notice of Effectiveness
- 8-K Event Unregistered share sale · Regulation FD disclosure
Page 17 of 21 · 416 filings